Jiangsu Cowin Biotech (688426.SH): Human Septin9, SDC2, and NDRG4 gene methylation test kits have obtained three types of medical device registration certificates.

Jiangsu Cowin Biotech (688426.SH) announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd. (referred to as "Jianwei Diagnostic"), recently received a Class III "Medical Device Registration Certificate" from the National Medical Products Administration for the independently developed and produced human Septin9, SDC2, and NDRG4 gene methylation detection kit (fluorescent PCR method). As of the date of the announcement, this is the first Class III registration certificate for colorectal cancer auxiliary diagnosis for Jianwei Diagnostic's independently developed and produced human Septin9, SDC2, and NDRG4 gene methylation detection kit (fluorescent PCR method). It is also the fifth certificate based on fecal samples and the seventh certificate in the field of digestive system for the company. The acquisition of the above certificates will help enhance the company's comprehensive competitiveness in colorectal cancer auxiliary diagnosis testing and digestive system diagnosis, and will have a positive impact on the company's sales and business expansion.